NCT02808663View on ClinicalTrials.gov

Assessment of the Predictive Value of Fecal Calprotectin for the Outcome of Severe Alcoholic Hepatitis

NACompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

May 6, 2015

Primary Completion Date

February 1, 2017

Study Completion Date

February 1, 2017

Conditions
Severe Alcoholic Hepatitis
Interventions
BIOLOGICAL

fecal calprotectin concentration

BIOLOGICAL

blood collection

Trial Locations (1)

51092

Chu Reims, France

All Listed Sponsors
lead

CHU de Reims

OTHER

NCT02808663 - Assessment of the Predictive Value of Fecal Calprotectin for the Outcome of Severe Alcoholic Hepatitis | Biotech Hunter | Biotech Hunter